Shrinking Staffs
Biotech now looks to products.
A spate of layoff announcements in June offers further evidence that biotech firms are getting serious about ditching drug discovery in favor of product development, despite the recent excitement over drug product approvals and a healthy run-up in biotech stocks.
 |
 |
News Analysis
Ready or Not
Vive la Differentiation!
» Shrinking Staffs
Double Attack
Bull�s-Eye?
Biotech Buys
Sniffing for SNPs
|